EUVIMEDEUVIMED entdecken
Crossref

The Synergistic Potential of Rationally Designed Phenol-Triazole Derivatives to Attenuate Aβ/Cu 2+ –Aβ Aggregation and Reactive Oxygen Species

Gagandeep Kaur, Opinder Kaur Mankoo iD, Amandeep Kaur, Sukhmani Mann, Nitesh Priyadarshi, Prit Pal Singh iD, Bhupesh Goyal iD, Nitin Kumar Singhal iD, Deepti Goyal iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Gagandeep Kaur und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Basic and Applied Sciences, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Punjab 140406, India. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Reactive Oxygen Species, Copper, Peptide Fragments. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a neurological disorder characterized by a spectrum of symptoms such as memory loss and cognitive decline. AD is a multifaceted disease, and designing multipotent ligands is an effective strategy for AD treatment. In this regard, the pharmacophore moiety of clioquinol (CQ, metal chelator) was employed to design the multifunctional phenol-triazole derivatives 4(a-p). In particular, 4k with an o-I group on the phenyl ring displayed a noteworthy higher inhibition (inhibition efficiency 4k = 90.5%, IC50 = 6.51 ± 0.01 μM) against Aβ42 aggregation as compared to 38.1% noted for CQ. Furthermore, 4k significantly disassembled the preformed Aβ42 fibrils (Aβf, 92.5%), chelated Cu2+ ions, and inhibited Cu2+-mediated Aβ42 aggregation. Compound 4k ceases the production of reactive oxygen species (ROS) as it acts as an antioxidant due to the presence of a phenolic hydroxyl group. Compound 4k has a sufficient safety-efficacy profile and alleviates the cytotoxicity by Aβ42 aggregates in PC-12 cells. For studying the modulation in the fibrillary architecture, hydrodynamic size, and structural transition of Aβ42 in the presence of 4k, we resorted to transmission electron microscopy (TEM), dynamic light scattering (DLS), and circular dichroism (CD), respectively. The molecular dynamics (MD) simulations depicted a notable reduction in the conformational transformations in the Aβ42 monomer (Aβm) and Aβf on the incorporation of 4k. Compound 4k modulates Aβ42 fibrillation by maintaining a helix conformation and simultaneously reduces the sampling of β-sheet structures in Aβm, consistent with the CD results. The molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) analysis depicted a favorable binding of 4k to Aβm (-42.12 ± 7.14 kcal/mol) and Aβf (-74.42 ± 4.98 kcal/mol) with a significant contribution of van der Waals interactions to the binding free energy. The 4k-induced deformation in Aβf chains noted in the conformational snapshots depicts its destabilization potential against Aβf. Finally, our results uncovered the potential of phenol-triazole derivatives as a promiscuous ligand for targeting various pathological conditions in AD. The key insights into the prevention of conformational transitions in Aβm and destabilization of Aβf by 4k illuminated by experimental and computational studies are central to unraveling the molecular understanding of amyloid aggregation as well as designing future therapeutic candidates against multifaceted AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesReactive Oxygen SpeciesCopperPeptide FragmentsTriazolesAnimalsRatsPC12 CellsChelating AgentsClioquinolProtein AggregatesPhenolsProtein Aggregation, Pathological

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloid-β aggregation inhibitormetal chelatormolecular dynamicsphenol-triazole derivativesreactive oxygen species

Substanzen

Amyloid beta-PeptidesReactive Oxygen SpeciesCopperPeptide FragmentsTriazolesamyloid beta-protein (1-42)Chelating AgentsClioquinolProtein AggregatesPhenols

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Basic and Applied Sciences, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Punjab 140406, India.
  • National Agri-Food and Biomanufacturing Institute, S.A.S. Nagar, Punjab 140306, India.
  • Department of Chemistry and Biochemistry, Thapar Institute of Engineering & Technology, Patiala, Punjab 147004, India.
  • Department of Chemistry, DAV College, Sector-10, Chandigarh 160011, India.

ORCID-Profile: Opinder Kaur Mankoo, Prit Pal Singh, Bhupesh Goyal, Nitin Kumar Singhal, Deepti Goyal

Förderung

  • Council of Scientific and Industrial Research, India
  • Science and Engineering Research Board

Zitieren

APA

Kaur, G., Mankoo, O. K., Kaur, A., Mann, S., Priyadarshi, N., Singh, P. P., Goyal, B., Singhal, N. K., & Goyal, D. (2025). The Synergistic Potential of Rationally Designed Phenol-Triazole Derivatives to Attenuate Aβ/Cu 2+ –Aβ Aggregation and Reactive Oxygen Species. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00386

Vancouver

Kaur G, Mankoo OK, Kaur A, Mann S, Priyadarshi N, Singh PP, et al. The Synergistic Potential of Rationally Designed Phenol-Triazole Derivatives to Attenuate Aβ/Cu 2+ –Aβ Aggregation and Reactive Oxygen Species. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00386

BibTeX
@article{Kaur2025,
  author = {Kaur, Gagandeep and Mankoo, Opinder Kaur and Kaur, Amandeep and Mann, Sukhmani and Priyadarshi, Nitesh and Singh, Prit Pal and Goyal, Bhupesh and Singhal, Nitin Kumar and Goyal, Deepti},
  title = {The Synergistic Potential of Rationally Designed Phenol-Triazole Derivatives to Attenuate Aβ/Cu 2+ –Aβ Aggregation and Reactive Oxygen Species},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00386}
}
Kostenlos starten →